News

Antibody Discovery Strategic Business Report 2025 | Monoclonal Antibody Segment Set for Significant Expansion, Reaching $2 Billion by 2030
Antibody discovery, crucial for developing targeted therapies in fields like oncology and autoimmune diseases, is evolving ...
Natural Science News1d
Sequence vs Structure: Grouping Antibodies in Simulated Data
Researchers show that analyzing the 3D shapes of antibodies, not just their genetic sequences, can better group functionally ...
News-Medical.Net3d
New antibody discovery reveals powerful immune defense against tuberculosis
Researchers at the Ragon Institute have made a significant discovery about how antibodies can directly enhance the body's ...
Antibody-mediated protection mechanism expands tuberculosis treatment options
Researchers at the Ragon Institute have made a significant discovery about how antibodies can directly enhance the body's ...
TMCnet3d
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting
NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentations of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of ...
ascopubs.org3d
Dose escalation and expansion from the phase I study of DS-1062, a trophoblast cell-surface antigen 2 (TROP2) antibody drug conjugate (ADC), in patients (pts) with advanced non ...
FLT3 ligand (CDX-301) and stereotactic radiotherapy for advanced non-small cell lung cancer. This is an ASCO Meeting Abstract from the 2020 ASCO Annual Meeting I. This abstract does not include a full ...
PharmiWeb6d
Glycan Cartography Mapping the Uncharted Territories of Cell Communication
The Hidden Language of GlycansImagine a vast molecular conversation happening within and between cells—where sugar-based structures act as sophisticated messengers carrying critical biological ...